U-TENK

Q:TENK - TENX KEANE ACQUISITION - Website unknown - click to update

23:24:30 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
TENK - Q	0.1	4.61	·	12.58	0.7	11.48	-0.05	-0.4	0.7	8	2	11.44 11.48 11.43	12.03 10.64	09:50:35	Jul 10	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - All 2 today

More trades...

Time ET	Ex	Price	Change	Volume
09:50:35	Q	11.43	-0.05	400
09:50:35	Q	11.4301	-0.0499	100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-07-10 09:10	U:TENK	News Release200	Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates
2024-01-10 14:29	U:TENK	News Release200	TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
2023-10-24 07:30	U:TENK	News Release200	Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
2023-10-18 16:00	U:TENK	News Release200	TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

Date ET

Symbol

Type

Headline

2024-07-10 09:10

U:TENK

News Release

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

2024-01-10 14:29

U:TENK

News Release

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal